Cubist Systematic Strategies, LLC Bio N Tech Se Put Options Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $518,187 - $642,675	-5,700 Reduced 75.0%	1,900 $200,000
Q3 2023 Nov 14, 2023	SELL	$98.5 - $125.08 $728,900 - $925,592	-7,400 Reduced 49.33%	7,600 $825,000
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $441,094 - $557,538	-4,300 Reduced 22.28%	15,000 $1.62 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $1.86 Million - $2.34 Million	15,200 Added 370.73%	19,300 $2.4 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $485,563 - $762,805	4,100 New	4,100 $615,000
Q2 2022 Aug 15, 2022	BUY	$123.25 - $186.24 $554,625 - $838,080	4,500 New	4,500 $671,000

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.